154
Participants
Start Date
August 23, 2016
Primary Completion Date
July 15, 2019
Study Completion Date
July 15, 2019
Investigational Medical Product (IMP) administered in parent study
IMP as administered in parent study. IMP would have been either placebo, tanezumab, celecoxib, naproxen or diclofenac administered in parent study.
Clinical Horizons NZ Ltd, Tauranga
CMAX Clinical Research Pty Ltd, Adelaide
Tolna Megyei Balassa Janos Korhaz, Ortopediai Osztaly, Szekszárd
Drug Trials America, Hartsdale
Institute of Rheumatology, Belgrade
Rheumazentrum Prof. Dr. med Gunther Neeck, Bad Doberan
Founders Research Corporation, Philadelphia
Spectrum Medical, Inc., Danville
North Georgia Clinical Research, Woodstock
North Georgia Internal Medicine, Woodstock
Masters of Clinical Research, Inc., Augusta
Clinical Neuroscience Solutions, Inc., Jacksonville
Sunshine Research Center, Opa-locka
Clintex Research Group, Miami
JEM Research Institute, Atlantis
Orthopedic Research Institute, Boynton Beach
Stedman Clinical Trials, Tampa
Orthopaedic Associates of West Florida, Clearwater
Kennedy White Orthopaedic Center, Sarasota
Renstar Medical Research, Ocala
American Family Medical, Ocala
Central Alabama Research, Birmingham
Alabama Clinical Therapeutics, LLC, Birmingham
Alabama Orthopaedic Surgeons, Birmingham
Cahaba Research Inc., Birmingham
Remington-Davis, Incorporated, Columbus
Optimed Research LTD, Columbus
AC Clinical Research, Tiffin
Great Lakes Research Group, Incorporated, Bay City
Orthopaedic Associates of Michigan, PC, Grand Rapids
Chicago Clinical Research Institute, Inc., Chicago
Northwestern University, Chicago
Physician Research Collaboration, LLC, Lincoln
Best Clinical Trials, LLC, New Orleans
George Stanley Walker, MD, New Orleans
Baptist Health Center for Clinical Research, Little Rock
ClinRx Research, Richardson
Abigail R. Neiman, MD, PA, Houston
Advances In Health, Houston
Mercury Clinical Research, Inc., Houston
BI Research Center, Houston
Mercury Clinical Research, Webster
DCT - Stone Oak, LLC dba Discovery Clinical Trials, San Antonio
Injury Care Research, Boise
Noble Clinical Research, Tucson
Hope Clinical Research, Canoga Park
California Research Foundation, San Diego
Advances in Medicine, Palm Desert
Marvel Clinical Research, LLC, Huntington Beach
CITrials, Santa Ana
Advanced Research Center, Inc., Anaheim
Clinical Trials Research, Sacramento
Northwest Clinical Research Center, Bellevue
Medical Technologies Ltd., Saint Petersburg
Stamford Therapeutics Consortium, Stamford
Gulfcoast Research Institute, LLC, Sarasota
Professional Research Network of Kansas, LLC, Wichita
Dawson Road Medical Centre, Guelph
Rebecca Medical Associates, Oakville
Recherche Clinique Sigma inc, Québec
Centre de recherche Saint-Louis, Québec
Azienda Ospedaliero-Universitaria E Policlinico Umberto I, Rome
Omuro Orthopedic Clinic, Himeji
Nakajo Orthopedic Clinic, Sendai
Marunouchi Hospital, Matsumoto
National Hospital Organization Osaka Minami Medical Center, Kawachi-Nagano
Osaka University Hospital, Suita
Saules seimos medicinos centras, Kaunas
South Pacific Clinical Trials, Auckland
Star Unit, North Shore Hospital, Waitemata District Health Board, Auckland
Southern Clinical Trials- Waitemata Ltd, Auckland
Hospital Conde de Bertiandos, Ponte de Lima
Kompan, s.r.o., Dolný Kubín
Slovak Research Center Team Member, MUDr. Viliam Cibik, PhD, s.r.o., Pruské
Instituto de Ciencias Medicas, Alicante
Hospital del Mar, Barcelona
Ladulaas Kliniska Studier, Boras, Sweden
ProbarE I Lund AB, Lund
ProbarE i Stockholm AB, Stockholm
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Pfizer
INDUSTRY